Novo Nordisk
NVO
#16
Rank
โ‚น41.635 T
Marketcap
โ‚น9,070
Share price
-1.53%
Change (1 day)
12.48%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น951.26 Billion

According to Novo Nordisk's latest financial reports the company has โ‚น951.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น372.71 B32.68%
2022-12-31โ‚น280.92 B41.78%
2021-12-31โ‚น198.13 B28.48%
2020-12-31โ‚น154.21 B-6.79%
2019-12-31โ‚น165.45 B-1.24%
2018-12-31โ‚น167.52 B-13.67%
2017-12-31โ‚น194.05 B-2.56%
2016-12-31โ‚น199.15 B-0.07%
2015-12-31โ‚น199.30 B21.05%
2014-12-31โ‚น164.64 B-0.52%
2013-12-31โ‚น165.49 B5.85%
2012-12-31โ‚น156.35 B-3.06%
2011-12-31โ‚น161.29 B25.66%
2010-12-31โ‚น128.36 B11.97%
2009-12-31โ‚น114.64 B24.71%
2008-12-31โ‚น91.92 B62.08%
2007-12-31โ‚น56.71 B41.54%
2006-12-31โ‚น40.07 B12.08%
2005-12-31โ‚น35.75 B13.67%
2004-12-31โ‚น31.45 B31.84%
2003-12-31โ‚น23.85 B101.7%
2002-12-31โ‚น11.82 B-43.25%
2001-12-31โ‚น20.84 B147.18%
2000-12-31โ‚น8.43 B7.68%
1999-12-31โ‚น7.83 B63.3%
1998-12-31โ‚น4.79 B-23.29%
1997-12-31โ‚น6.25 B34.34%
1996-12-31โ‚น4.65 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น843.94 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น298.36 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น686.38 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น617.70 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France